BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8281363)

  • 1. Estrogen: risk versus benefit for the prevention of coronary artery disease.
    LaRosa JC
    Coron Artery Dis; 1993 Jul; 4(7):588-94. PubMed ID: 8281363
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of estrogen on cardiovascular disease. The Lipid Research Clinics Program.
    Bush T
    Postgrad Med; 1989 Apr; Spec No():45-8; discussion 89-90. PubMed ID: 2657699
    [No Abstract]   [Full Text] [Related]  

  • 3. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of cardiovascular diseases by hormone replacement in postmenopause].
    Windler E
    Zentralbl Gynakol; 1996; 118(4):188-97. PubMed ID: 8651005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of estrogen treatment in prevention of ischemic heart disease in menopausal women].
    Roig Minguell E
    Rev Esp Cardiol; 1994; 47 Suppl 3():22-6. PubMed ID: 7816976
    [No Abstract]   [Full Text] [Related]  

  • 6. Aggressive medical therapy for the prevention and treatment of coronary artery disease.
    Malloy MJ; Kane JP
    Dis Mon; 1998 Jan; 44(1):1-40. PubMed ID: 9457050
    [No Abstract]   [Full Text] [Related]  

  • 7. Improving the prediction of cardiovascular risk: interaction between LDL and HDL cholesterol.
    Grover SA; Dorais M; Coupal L
    Epidemiology; 2003 May; 14(3):315-20. PubMed ID: 12859032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM
    Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy and cardiovascular disease: the human model.
    Sullivan JM
    Br J Obstet Gynaecol; 1996 May; 103 Suppl 13():59-65; discussion 66-7. PubMed ID: 8624345
    [No Abstract]   [Full Text] [Related]  

  • 10. [The control of cholesterol in the prevention of coronary cardiopathy].
    Vintró IB
    Rev Esp Salud Publica; 1995; 69(6):439-43. PubMed ID: 8789356
    [No Abstract]   [Full Text] [Related]  

  • 11. Patient profile: primary prevention.
    Bruckert E
    Int J Clin Pract Suppl; 2002 Jul; (130):4-5. PubMed ID: 12296607
    [No Abstract]   [Full Text] [Related]  

  • 12. [Coronary risk factors in children of young coronary artery disease patients].
    Forti N; Diogo Giannini S; Diament J; Issa J; Fukushima J; Dal Bó C; Pereira Barretto AC
    Arq Bras Cardiol; 1996 Mar; 66(3):119-23. PubMed ID: 8762687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age.
    Weverling-Rijnsburger AW; Jonkers IJ; van Exel E; Gussekloo J; Westendorp RG
    Arch Intern Med; 2003 Jul; 163(13):1549-54. PubMed ID: 12860577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of cardiovascular risk factors in patients after coronary artery bypass grafting with an in-hospital rehabilitation programme (WHO Stage I of Rehabilitation): 1-year follow-up].
    Schimmer C; Krannich JH; Brauchle-Hopp U; Elert O
    Rehabilitation (Stuttg); 2006 Apr; 45(2):95-101. PubMed ID: 16575715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.
    Santos RD; Waters DD; Tarasenko L; Messig M; Jukema JW; Ferrières J; Verdejo J; Chiang CW;
    Am Heart J; 2009 Nov; 158(5):860-6. PubMed ID: 19853709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationships between intravascular ultrasonographic findings and coronary risk factors in patients with normal coronary angiography].
    Noike H; Hitsumoto T; Sakurai T; Sugiyama Y; Sato S; Iizuka T; Takahashi M; Shimizu K; Nakamura K; Ohsawa H
    J Cardiol; 2005 Jan; 45(1):1-10. PubMed ID: 15700924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
    Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
    Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The trend of coronary risk factors in Schwedt (Oder)].
    Gräfner L; Gräfner J; Heinrich J; Knappe J
    Z Arztl Fortbild (Jena); 1989; 83(10):523-7. PubMed ID: 2750215
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hormone replacement therapy and cardiovascular risk].
    Maffei S; De Caterina R
    G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.